Crossject Société Anonyme (EPA:ALCJ)
France · Delayed Price · Currency is EUR 1.964
+0.024 (1.24%)
At close: Mar 13, 2026
Crossject Société Anonyme Market Cap
Crossject Société Anonyme has a market cap or net worth of €103.58 million as of March 13, 2026. Its market cap has increased by 14.14% in one year.
Market Cap
103.58M
Enterprise Value
117.53M
Revenue
4.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.96
Market Cap Chart
Since February 20, 2014, Crossject Société Anonyme's market cap has increased from 59.40M to 103.58M, an increase of 74.38%. That is a compound annual growth rate of 4.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 103.58M | -10.32% |
| Dec 31, 2025 | 115.50M | 10.53% |
| Dec 31, 2024 | 104.50M | -44.71% |
| Dec 29, 2023 | 188.99M | 90.83% |
| Dec 30, 2022 | 99.04M | 26.25% |
| Dec 31, 2021 | 78.44M | 0.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 96.99B |
| Sanofi | 92.07B |
| Sartorius Stedim Biotech | 15.63B |
| Ipsen | 12.82B |
| Innate Pharma | 126.53M |
| Euroapi | 124.54M |
| Adocia | 118.93M |
| ABIONYX Pharma | 118.53M |